Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Pharmacokinetics and tolerability of three ordopidine dose levels in volunteers

Trial Profile

Pharmacokinetics and tolerability of three ordopidine dose levels in volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 26 Jun 2008

At a glance

  • Drugs Ordopidine (Primary)
  • Indications Bipolar disorders; Parkinson's disease
  • Focus Pharmacokinetics
  • Sponsors NeuroSearch
  • Most Recent Events

    • 26 Jun 2008 Status changed from in progress to completed, according to a NeuroSearch media release (9090561).
    • 10 Nov 2006 The expected completion date for this trial is now 30 Jun 2007.
    • 10 Nov 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top